WO2012030130A2 - 수크로오즈와 글리세롤을 동시에 이용하는 신규 숙신산 생성 변이 미생물 및 이를 이용한 숙신산 제조방법 - Google Patents
수크로오즈와 글리세롤을 동시에 이용하는 신규 숙신산 생성 변이 미생물 및 이를 이용한 숙신산 제조방법 Download PDFInfo
- Publication number
- WO2012030130A2 WO2012030130A2 PCT/KR2011/006382 KR2011006382W WO2012030130A2 WO 2012030130 A2 WO2012030130 A2 WO 2012030130A2 KR 2011006382 W KR2011006382 W KR 2011006382W WO 2012030130 A2 WO2012030130 A2 WO 2012030130A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- succinic acid
- glycerol
- sucrose
- producing
- mutant
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- the present invention relates to a succinic acid-producing mutant microorganism which can simultaneously use sucrose and glycerol as a carbon source. More particularly, the present invention relates to succinic acid-producing microorganisms. It relates to a mutant microorganism that can be used simultaneously with and glycerol.
- Succinic acid is a 4-carbon dicarboxylic acid with various industrial applications.
- Succinic acid is adipic acid, 1, 4-butanediol, ethylene diamine disuccinate, itaconic acid, gamma butyrolactone ⁇ -aminobutyric acid, and tetrahydrofuran are used as precursors for industrially important chemicals, and the market size of succinic acid is known to be around $ 15 billion (McKinlay). etal. , Appl. Microbiol. Biotechnol., 76: 727, 2007) . In recent decades, bio-based succinic acid production has been Global studies have been conducted (McKinlay et al. , Appl. Microbiol.).
- Sucrose is equivalent to one-quarter of the glucose price normally used for succinic acid production through microbial fermentation, and glycerol is a by-product, accompanied by the rapid growth of the global biodiesel production industry, resulting in lower prices and proper disposal due to oversupply.
- the development of the method is required and, therefore, its price is very low and it is continuously decreasing (Miller-Klein Associates, Oct. 2006).
- microorganisms selectively utilize preferred carbon sources from mixtures of various kinds of carbon sources.
- most microorganisms have a catabolite repression mechanism that inhibits the use of non-preferred carbon sources when there is a preferred carbon source (Gorke et al. , Nature Reviews, 6: 613,2008).
- Selective use of carbon sources by the dihydrate inhibition mechanism is best known in the case of coexistence of glucose and lactose in E. coli, discovered by Monod in 1942, in the second stage (diauxie) growth.
- the preferred carbon source is glucose, and thus lactose, a non-preferred carbon source, shows a growth curve that begins to be consumed after a slight delay after all of the glucose is consumed.
- glycerol is used as a carbon source, due to the high reduced degree of glycerol, it is twice as high as the sugars such as glucose, xylose, and sucrose to produce phosphoenolpyruvate (PEP), an intermediate of glycolysis. It produces a number of reducing equivalents (NADH, NADPH, FADH 2, etc.), making it a particularly popular carbon source for the production of reducing chemicals (Yazdani et al. , Curr.
- glycerol can be used faster than glycerol, and saccharides such as sucrose can be used to increase cell growth at higher and faster rates, glycerol can also be used. It can be used as an effective production strategy in the production of reducing chemicals, especially in the production of succinic acid, by rapidly growing the cell while taking advantage of the excellent reducing power.
- the present inventors have made efforts to develop a method of producing high-purity succinic acid with high efficiency while simultaneously using low-cost sucrose and glycerol, resulting in deletion of a gene encoding fructose phosphotransferase in succinic acid-producing microorganisms.
- the mechanism of inhibiting catabolism is weakened, so that succinic acid can be produced by using sucrose and glycerol simultaneously, while minimizing by-products and producing pure succinic acid with high efficiency.
- the present invention was confirmed to be close to the world's highest level.
- An object of the present invention is to develop a strain that can be used at the same time sucrose and glycerol, while maximizing the yield of succinic acid to the theoretical level, while simultaneously minimizing the production of other by-products, the production of pure succinic acid, the catabolism inhibition mechanism Attenuated mutations provide for microorganisms.
- Another object of the present invention is to provide a method for producing succinic acid purely without producing by-products other than succinic acid by using sucrose and glycerol as carbon sources under the anaerobic conditions.
- the present invention in the succinic acid-producing microorganisms, attenuates the mechanism of inhibiting catabolic products of glycerol by sucrose, thereby providing a mutant microorganism which can simultaneously use sucrose and glycerol for succinic acid production.
- the present invention also provides a method for producing mutant microorganisms in which succinic acid-producing microorganisms attenuate the mechanism of inhibiting catabolic products of glycerol by sucrose to simultaneously use sucrose and glycerol for succinic acid production.
- the present invention also provides a method for producing succinic acid comprising culturing the succinic acid-producing mutant microorganisms under anaerobic conditions and recovering succinic acid from the culture solution.
- Figure 1 illustrates the sucrose and glycerol metabolic pathways and catabolic inhibition mechanism in the strains of Maniaia.
- Figure 1A shows the metabolic pathways of sucrose and glycerol and the metabolic inhibitory mechanism between them, and Figure 1B shows which part of A can be attenuated by metabolic engineering. .
- GLY glycerol; G3P, glycerol 3-phosphate
- SCR sucrose
- G6P glucose 6-phosphate
- FRU fructose
- F1P fructose 1-phosphate
- FBP fructose 1,6-bisphosphate
- PEP phosphoenolpyruvate
- SUC succinic acid
- PYR pyruvic acid
- IIBCF fructose PTS IIBC unit
- IIBCS sucrose PTS IIBC unit
- EI enzyme I
- HPr histidine protein
- IIA PTS enzyme IIA
- Fpr bifunctional fructose-specific IIA / HPr protein
- AC adenylate cyclase
- cAMP cyclic AMP
- CRP cAMP receptor protein
- M.succiniciproducens PALK (A)
- B a fed-batch culture growth and metabolite production curve of M.succiniciproducens PALFK
- C M. succiniciproducens PALKG
- Figure 3 is a growth and metabolite production curve of fed- batch culture with increased inoculation of M. succiniciproducens PALFK strain.
- Figure 4A is a schematic diagram showing the MCRB culture method, the solid line represents the flow of liquids (medium, medium containing cells, the medium containing metabolites, etc.), the dotted line indicates the flow of gas (carbon dioxide) It is.
- B shows growth and metabolite production curves when M. succiniciproducens PALFK strains were cultured using the MCRB culture method.
- the present invention relates to a mutant microorganism in which succinic acid-producing microorganisms attenuate the mechanism of inhibiting catabolic product of glycerol by sucrose and simultaneously use sucrose and glycerol for succinic acid production.
- catabolic product inhibition mechanism when microorganisms are cultivated in a medium in which various kinds of carbon sources are present, selectively utilizes a preferred carbon source, and in order to enable this, most microorganisms have a preferred carbon source. In addition, it has a mechanism of inhibiting the use of non-preferred carbon sources, and this is called a metabolite inhibition mechanism (Gorke et al. , Nature Reviews, 6: 613,2008).
- sucrose and glycerol could not be used simultaneously for succinic acid production due to the mechanism of inhibiting dihydrate.
- sucrose which is a preferred carbon source
- glycerol is consumed later.
- sucrose is preferred, so if sucrose and glycerol are present at the same time, sucrose is metabolized at a higher rate.
- Allosteric inhibition refers to the deactivation of fructose 1,6-bisphosphate (FBP) or EIIA by binding to glycerol kinase, which plays a key role in glycerol metabolism.
- FBP fructose 1,6-bisphosphate
- EIIA glycerol kinase
- Figure 1 illustrates the sucrose and glycerol metabolic pathways and catabolic inhibition mechanism in the strains of Maniaia.
- Figure 1A shows the metabolic pathways of sucrose and glycerol and the metabolic inhibitory mechanism between them, and Figure 1B shows which part of A can be attenuated by metabolic engineering.
- Solid arrows indicate the metabolic pathway of sucrose or glycerol, and the thickness indicates the relative metabolic rate.
- the dashed arrows represent the continuous delivery of the phosphoryl group from PEP to the PTS IIBC unit, and the thick dotted arrows represent the various pathways that can induce the expression of glp operon.
- the mechanism of inhibiting catabolism between sucrose and glycerol is largely composed of transcriptional inhibition by GlpR and allosteric inhibition by FBP and EIIA.
- Fig. 1B there are various methods such as inducing the generation of various activators to overcome transcriptional inhibition and alleviating allosteric inhibition against GlpK by lowering the concentration of FBP or IIA.
- the phosphorylated IIA is increased relatively to induce the expression of AC, thereby generating more cAMP, thereby increasing the production of CRP-cAMP.
- the G3P produced by the expressed GlpK further reduces the transcriptional factor GlpR from the binding sites of the glp regulator (glpABC, glpF, glpK, etc.) DNA to facilitate the transcription of the genes of the glp regulator.
- the relatively unphosphorylated IIA concentration is kept low, and as the overall metabolism of sucrose decreases due to the elimination of IIBCF, the FBP concentration is relatively decreased, thereby alleviating allosteric inhibition. According to the simultaneous effect of urea, the overall increase in glycerol metabolism.
- the phosphorylated IIA concentration is increased in (2) of FIG. 1B to induce the expression of AC, thereby producing more cAMP, thereby increasing the production of CRP-cAMP, and thus inducing the expression of glp operon.
- the G3P produced by the expressed GlpK additionally lowers the transcription inhibitor GlpR from the binding site of the glp regulatory DNA, thereby facilitating the transcription of the genes of the glp regulatory gene, thereby improving overall glycerol metabolism. How to import.
- G3P produced by the expressed GlpK additionally drops GlpR, which is a transcriptional inhibitor, from the binding sites of the glp regulatory DNA, thereby facilitating the transcription of the genes of the glp regulatory gene, resulting in an overall increase in glycerol metabolism. to be.
- G3P produced by the expressed GlpK additionally drops GlpR, which is a transcriptional inhibitor, from the binding sites of the glp regulatory DNA, thereby facilitating the transcription of the genes of the glp regulatory gene, leading to an overall increase in glycerol metabolism. Way.
- GlpK overexpression is induced to increase the production of G3P, which causes GlpR, a transcription inhibitory element, to be dropped from the binding sites of glp regulatory DNA. There is a way to more smoothly and eventually increase the overall glycerol metabolism.
- a method of blocking the inhibition by GlpR is introduced by introducing an overexpression promoter that does not have a position to which GlpR can bind to a promoter site for expression of each transcription unit of glp regulator on a chromosome.
- an overexpression promoter that does not have a position to which GlpR can bind to a promoter site for expression of each transcription unit of glp regulator on a chromosome.
- glycerol kinases from heterologous strains designed to be relatively less susceptible to or less resistant to allosteric inhibition.
- overexpressing there may be a method of bringing the overall increase of glycerol metabolism, and other methods other than the above-mentioned method may be a method for active metabolism of glycerol by attenuating the metabolism inhibition mechanism.
- succinic acid is a representative example of such a reducing chemical, a C4 chemical having two carboxyl groups having PEP (phosphoenolpyruvate) as an intermediate precursor.
- succinic acid-producing microorganisms are microorganisms that produce succinic acid in excess of other metabolites, and mean microorganisms that can be industrially used for succinic acid production by fermentation.
- Representative succinic acid-producing microorganisms include lumen bacteria, which include Actinobacillus genus, Anaerobiospirillum genus, and Mannheimia genus (including Basfia rates.
- Basfia genus was originally named Mannheimia genus when isolated, but later separated into Bafia genus.
- 16S rRNA sequences are also very similar strains, such as 99.8% match, and so including all of them in the genus Mannheimia , Scholten et al., WO2009 / 024294A1; Kuhnert et al., Int. J. Syst. Evol. Microbiol., 60 (44) is known.
- the succinic acid-producing microorganisms may be characterized in that the lumen bacteria, the lumen bacteria are genus Mannheimia sp . , Actinobacillus sp . Actinobacillus sp . And un-aerobiopyrilium ( Anaerobiospirillum sp . It may be characterized in that selected from the group consisting of.
- the Mannheimia succiniciproducens PALK (KCTC10973BP) to said Mannheimia spp.
- the weakening of the catabolic inhibitory mechanism may be performed by deleting a gene encoding fructose phosphotransferase, and the mutant microorganism may be characterized by Mannheimia succiniciproducens PALFK (KCTC11694BP). have.
- the weakening of the catabolic inhibitory mechanism may be performed by introducing a gene encoding a glycerol kinase, and may be characterized in that the succinic acid-producing mutant microorganism Mannheimia succiniciproducens PALFK (KCTC11694BP).
- a succinic acid-producing mutant microorganism is produced which does not produce any other organic acid while maximizing the yield of succinic acid through genetic manipulation of lumen bacteria, succinic acid producing microorganisms.
- Mannheimiasucciniciproducens PALK sikimeuroseo deletions of genomic DNA fructose fructose phosphorylation transferase gene (fruA) encoding the cyclase in (KCTC10973BP), a strain that has the capability to and at the same time metabolic sucrose metabolism glycerol M
- succiniciproducens PALFK KCTC11694BP
- the deletion of each gene was used to inactivate the gene using the homologous recombination method, but if the genetic modification method that can modify or remove the gene so that the enzyme encoded by the gene is not produced Can be used without limitation.
- Cultivation of succinic acid-producing mutant microorganisms and obtaining succinic acid according to the present invention can be carried out using a culture method and a separate purification method of succinic acid conventionally known in the conventional fermentation process.
- M. succiniciproducens PALFK KCTC11694BP
- the mutant strain used for this is M. succiniciproducens PALK (KCTC10973BP).
- M. succiniciproducens PALK (KCTC10973BP) is a gene encoding lactic dehydrogenase ( ldhA ), a gene encoding phosphotransacetylase ( pta ), and a gene encoding acetic kinase ( ackA ) in the genome of the genus Mannheimia .
- a mutant microorganism that has been deleted is a parental strain that does not have the gene ( fruA ) encoding the fructose phosphotransferase in M. succiniciproducens PALFK (KCTC11694BP), which is the mutant microorganism according to the present invention.
- the succinic acid-producing mutant microorganism M. succiniciproducens PALFK (KCTC11694BP) according to the present invention minimizes the production of by-products such as lactic acid, pyruvic acid, acetic acid and formic acid, compared to M. succiniciproducens PALK (KCTC10973BP), a mutant strain used for succinic acid production.
- the yield of succinic acid is almost increased to the theoretical yield level (1.71 to 1.86 mol / mol), which is an excellent characteristic of the succinic acid producing strain.
- the present invention relates to a method for producing a mutant microorganism in which succinic acid-producing microorganisms attenuate the mechanism of inhibiting catabolic products of glycerol by sucrose and simultaneously use sucrose and glycerol for succinic acid production.
- KCTC10973BP Mannheimiasucciniciproducens PALK
- M. succiniciproducens PALKG a strain having the ability to metabolize glycerol while simultaneously metabolizing sucrose.
- Succinic acid producing mutant microorganism M. succiniciproducens PALKG (KCTC11693BP) according to the present invention was also compared in the same manner.
- the present invention relates to a method for producing succinic acid, comprising culturing the succinic acid-producing mutant microorganism under anaerobic conditions and recovering succinic acid from the culture medium.
- the culture may be characterized in that it is carried out in a medium containing sucrose and glycerol at the same time, the production amount of the other organic acid as the by-product may be characterized in that less than 1% of the succinic acid production weight.
- the present invention (a) attenuates the succinic acid-producing mutant microorganism having high yield and low by-product generation or the catabolic inhibition mechanism of glycerol by the sucrose, thereby simultaneously sucrose and glycerol in succinic acid production. Culturing the available variant microorganisms under anaerobic conditions; (b) concentrating the cell concentration in the culture solution at a high concentration; (c) culturing the high concentration of cells; And (d) recovering succinic acid from the culture solution.
- the step (b) concentrating the cell concentration in the culture medium to a high concentration may be carried out by the inoculation method (hereinafter referred to as 'inoculum method') or membrane cell recycling bioreactor (MCRB) method (injecting a high concentration of production strain at inoculation)
- 'inoculum method' the inoculation method
- MCRB membrane cell recycling bioreactor
- succinic acid using mutant microorganisms which can simultaneously use sucrose and glycerol to produce succinic acid according to the present invention, it is possible to produce succinic acid with high purity without any by-products, and the yield of succinic acid is close to theoretical yield. It can be produced in yield.
- sucrose is equivalent to one-quarter of the glucose price normally used for succinic acid production through microbial fermentation, and glycerol is generated as a by-product, along with the rapid growth of the global biodiesel production industry, resulting in lower prices and adequate supply. Development of treatment methods is required, and therefore their prices are very low and they are steadily decreasing (Miller-Klein Associates, Oct. 2006).
- a gene exchange vector was constructed as follows. First, the genomic DNA of M. succiniciproducens MBEL55E (KCTC0769BP) was used as a template, and the primers of SEQ ID NOS: 1 and 2, SEQ ID NOs: 3 and 4, and SEQ ID NOs: 5 and 6 were used to determine the fruA left homology region (HL) and chloramphenicol (Cm). PCR fragments containing resistance genes, and PCR fragments of each of the fruA right homology regions (HR) were obtained.
- M. succiniciproducens MBEL55E KCTC0769BP
- the mutant strain was prepared by deleting fruA in the genome of M. succiniciproducens PALK (KCTC10973BP) using the fruA gene removal vector pSacHR06fruA prepared in Example 1.
- M. succiniciproducens PALK (KCTC10973BP) was plated in a BHI (Brain-Heart Infusion) solid medium, incubated at 39 ° C. for 36 hours, and colonies were inoculated in 10 mL of BHI liquid medium and incubated for 12 hours. The fully grown cell culture solution was inoculated again with 100 mL of BHI liquid medium and incubated in a 39 ° C. stationary incubator.
- the bacterial culture solution is placed at 0-4 ° C. for 20 minutes to prevent the cell growth from further progressing, which is 4 ° C. and 4,500 rpm.
- Cells were obtained by centrifugation for 15 minutes at. Then, the cells were resuspended with 200 mL of 10% glycerol solution at 4 ° C., and then centrifuged again under the same conditions. The resuspension and centrifugation were performed three times while reducing the 10% glycerol solution in half. The final cell obtained was resuspended in an equal volume of 10% glycerol solution, aliquoted and stored at -80 ° C.
- the obtained cell concentrate was mixed with the gene removal vector pSacHR06fruA prepared in Example 1 and subjected to electroporation under conditions of 2.5 kV, 25 ⁇ F, and 200 ohms to transform M. succiniciproducens PALK (KCTC10973BP) with the vector. Tried.
- the electroporated cells were then incubated for 1 hour in a 39 ° C. stationary incubator by adding BHI liquid medium, and then the cultures were plated in a BHI solid medium containing 6.8 ⁇ g / mL of antibiotic chloramphenicol, and then in a 39 ° C. incubator. Incubated for at least 48 hours.
- the mutant strains formed in the medium were cultured in BHI liquid medium containing antibiotics, and genomic DNA of the culture strain was isolated by Rochelle et al. (Rochelle et al. , FEMS Microbiol. Lett. , 100: 59, 1992). PCR was performed using the genomic DNA of the isolated mutant strain as a template, followed by electrophoresis of the obtained PCR product to confirm the deletion of the fruA gene of the genomic DNA. Deletion of the fruA gene was confirmed by performing two PCRs as follows. First, the genomic DNA of the mutant strain was used as a template, and PCR was performed using primers of SEQ ID NOs: 7 and 8 and SEQ ID NOs: 9 and 10, respectively.
- KCTC11694BP M. succiniciproducens PALFK
- Example 3 Construction of pME18glpK22 vector and preparation of M. succiniciproducens PALKG strain
- Genomic DNA of Escherichia coli K-12 MG1655 was used as a template to obtain a DNA containing a gene encoding a Escherichia coli glycerol kinase ( glpK22 ), SEQ ID NOs: 11 and 12, PCR was performed using primers of SEQ ID NOs: 13 and 14 and SEQ ID NOs: 15 and 16, respectively.
- the three PCR products thus obtained were subjected to PCR again as a template to obtain a PCR product.
- the 913th base pair of the coding sequence was the guanine, which was originally contained in the glpK gene of E.
- glpK22 coli K-12 MG1655, to adenosine.
- the converted glpK22 gene is included, and the glycerol kinase expressed from this gene is known to be less susceptible to allosteric inhibition by FBP and IIA than glpK before the mutation (Pettigrew et al. , J. Bacteriol., 178). : 2846,1996).
- SEQ ID NO: 13 5'-TTTATACTTTCTACCCAAAAAGCTTCGCTGTAATATG
- SEQ ID NO: 16 5'-ACCTGCGAGCTCATTATTGATGTGTGCGGGGT
- the PCR product thus obtained was cloned into the Eco RI and Sac I sites in pME18 (Jang et al. , Appl. Environ. Microbiol. , 73: 5411, 2007) to complete the pME18glpK22 vector.
- Solgent Solgent, Korea
- SEQ ID NO: 17 5'-TAGCTATGTGTTAAAGCCTT
- SEQ ID NO: 19 5'-CCGATTACACCAACGCCTCT
- SEQ ID NO: 20 5'-ATGTGGTTCCGGCATTTACC
- the cell suspension was prepared in the same manner as in the preparation method and the electroporation method of Example 2, and instead of the antibiotic chloramphenicol, it was plated on BHI solid medium containing 25 ⁇ g / mL of ampicillin, followed by 48 hours in a 39 ° C. incubator. Incubated. After 8 hours of incubation in BHI liquid medium from pure colonies, the glycerol solution was mixed to a final concentration of 15% (w / v) and stored at -80 ° C until use.
- Example 4 M.succiniciproducens PALFK strain and the single acid production using a strain PALKG
- M. succiniciproducens PALFK (KCTC11694BP) or PALKG (KCTC11693BP) strains prepared in Examples 2 and 3 were prepared in 10 mL of MH5 medium containing 10 g / L sucrose (per liter, 2.5 g yeast extract, 2.5 g polypeptone, 1 g NaCl, 0.02 g CaCl 2 ⁇ 2 H 2 O, 0.2 g MgCl 2 ⁇ 6 H 2 O, 8.7 gK 2 HPO 4 , and 10.0 g NaHCO 3 ) incubated for 8 hours at 39 °C under anaerobic conditions, and then again the same medium Transfer to 300 mL and incubated.
- sucrose per liter, 2.5 g yeast extract, 2.5 g polypeptone, 1 g NaCl, 0.02 g CaCl 2 ⁇ 2 H 2 O, 0.2 g MgCl 2 ⁇ 6 H 2 O, 8.7 gK 2 HPO 4 , and 10.0 g NaHCO
- the fermentation was carried out with 2.5L of synthetic medium (per liter, 1g NaCl, 2g (NH 4 ) 2 HPO 4 , 0.02gCaCl 2 ⁇ 2H 2 O, 0.2gMgCl 2 ⁇ 6H 2 O, 8.709gK 2 HPO 4 , 0.5gcysteine a reactor containing a microorganism, 0.5gmethionine, 0.5galanine, 0.5gasparagine, 0.5gasparticacid , 2.46gproline, 0.5gserine, 0.005gnicotinicacid, 0.005gCa-pantothenate, 0.005gpyridoxine ⁇ HCl, 0.005g thiamine, 0.005g ascorbic acid and biotin 0.005g) (Bioflo 3000, New Brunswick Scientific Co., Edison, NJ, USA) and inoculated with fermentation conditions of 22.25 g / L (65 mM) initial sucrose concentration, 4.6 g /
- PALK succiniciproducens PALK (KCTC10973BP), a mutant strain for succinic acid production, was cultured for comparison with the performance of the PALFK strain.
- the cell concentration in the culture was measured using a spectrophotometer, and the cell concentration was calculated using the absorbance of the previously measured spectrophotometer and the weight verification line of the dry cells. Samples were periodically taken from the bioreactor during the fermentation process. The samples were centrifuged at 13,000 rpm for 10 minutes, and then the concentrations of various metabolites, succinic acid, sucrose and glycerol in the supernatant were analyzed by liquid chromatography (HPLC). ).
- M.succiniciproducens PALFK (KCTC11694BP) is compared with M. succiniciproducens PALK (KCTC10973BP) strain, it showed a more excellent acid production yields, and not at all produce by-product pure It can be seen that only succinic acid is produced.
- the amount of glycerol that is reduced to about the same amount as succinic acid increased by 7 times, which is relatively low because it does not mediate pyruvate production, which is directly related to by-product production, unlike when sucrose is used for uptake of glycerol. It is directly related to the production of by-products.
- the increased glycerol uptake also allows for the use of relatively small amounts of sucrose, yielding higher yields of succinic acid by producing only a single succinic acid with a lower carbon source.
- M. succiniciproducens PALKG shows a slightly different pattern from PALFK strain, which maintains pyruvate accumulation at PALK levels by increasing glycerol utilization within the range that does not inhibit sucrose availability and cell growth. Is that. Nevertheless, it shows more than twice the glycerol capacity compared to the PALK strain, resulting in succinic acid yield in 1.39 mol / mol, yielding higher yield of succinic acid than 1.24 mol / mol of PALK.
- PALFK strain reaches the maximum productivity after 13-15 hours after inoculation, it can be seen that the highest cell concentration at this time. Therefore, we first looked at the change in productivity when cell concentration was higher than the current level to maximize productivity.
- a microbial incubator Bioflo 3000
- PALFK was fermented and the cell concentration reached an OD 600 value of about 4.6.
- the culture was terminated, and the cell pellet was obtained by centrifuging the culture solution at 6000 rpm for 10 minutes at room temperature.
- the obtained cell pellet was again resuspended in 300 mL of MH5 medium to obtain a high concentration of inoculum.
- succinic acid productivity was 6.03 g / L / h (maximum interval productivity 10.69 g / L / h) at the original fermentation conditions. It can be seen that it increased more than two times, and the degree of byproduct formation and yield were almost similar.
- MCRB membrane cell recycling bioreactor
- the MCRB system used a hollow fiber membrane unit (CellFlo Plus Module; Spectrum Laboratories Inc., Collinso Dominguez, CA, USA) connected to a Bioflo 110 reactor (New Brunswick Scientific Co.) for cell circulation. Volume) was maintained at 0.4 L. The stirring speed in the incubator was maintained at 100 rpm, the speed of the diaphragm pump for cell recycling was maintained at 150 mL / min.
- CellFlo Plus Module Spectrum Laboratories Inc., Collinso Dominguez, CA, USA
- Bioflo 110 reactor New Brunswick Scientific Co.
- the composition of the synthetic medium was the same as that used in Example 4, and 0.5 g / L was added only for proline.
- the initial sucrose concentration in the incubator was 22.25 g / L and the initial glycerol concentration was 4.6 g / L.
- the feed tank 30 g / L sucrose and 21 g / L glycerol were used.
- the dilution rate (D) for the MCRB operation was maintained at 1.027 h ⁇ 1 and the cell bleeding rate, which determined growth at steady state, was maintained at 0.015 h ⁇ 1 .
- steady state means the minimum turnover time (the time it takes to fill the operation volume once when the culture is in progress, depending on the dilution rate.
- the productivity was increased to 10 times or more (29.73 g / L / h) of the parent strain.
- the yield of succinic acid was maintained as it is, the degree of by-products were also slightly higher than in the case of Example 4, it was found to maintain a low level.
- the succinic acid is produced in high productivity (29.73 g / L / h) with high efficiency (1.54 mol / mol) close to the theoretical yield as a strategy for increasing productivity after maximizing production yield and byproduct reduction. Succeeded.
- the succinic acid productivity presented in this example is more significant because it is ultra high productivity, which has not been achieved by any method before, and moreover was achieved while achieving a yield close to the theoretical value of 1.54 mol / mol.
- succinic acid-producing mutant microorganism By culturing the succinic acid-producing mutant microorganism according to the present invention, by using both sucrose and glycerol at the same time, it can be produced while maximizing the conventional fermentation yield near the theoretical yield and minimizing the by-products in succinic acid production. In addition, according to the present invention, it is possible to more effectively produce various kinds of reduced chemicals (reduced chemicals), which have conventionally had low production yields.
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (19)
- 숙신산 생성 미생물에 있어서, 수크로오즈에 의한 글리세롤의 이화산물 저해기작을 약화시켜, 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물.
- 제1항에 있어서, 숙신산 생성 미생물은 루멘박테리아인 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물.
- 제2항에 있어서, 상기 루멘박테리아는 맨하이미아 속 (Mannheimiasp.),액티노바실러스 속 (Actinobacillussp.)및 언에어로바이오스피리륨 (Anaerobiospirillumsp.)으로 구성된 군에서 선택되는 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물.
- 제3항에 있어서, 상기 맨하이미아 속 (Mannheimia sp.) 균주는 Mannheimia succiniciproducens PALK (KCTC10973BP)인 것을 특징으로 하는 수크로오즈와 글리세롤을 동시에 이용가능한 변이미생물.
- 제1항에 있어서, 숙신산 생성 미생물에 있어서, 이화산물 저해기작의 약화는 프룩토즈 포스포트랜스퍼라제를 코딩하는 유전자를 결실시켜 수행하는 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물.
- 제4항에 있어서, Mannheimia succiniciproducens PALFK (KCTC11694BP)인 것을 특징으로 하는 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물.
- 제1항에 있어서, 이화산물 저해기작의 약화는 글리세롤키나제를 코딩하는 유전자를 도입하여 수행하는 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 숙신산 생성 변이미생물.
- 제7항에 있어서, MannheimiasucciniciproducensPALKG(KCTC11693BP)인 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물.
- 숙신산 생성 미생물에서, 수크로오즈에 의한 글리세롤의 이화산물 저해기작을 약화시켜, 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물의 제조방법.
- 제9항에 있어서, 숙신산 생성 미생물은 루멘박테리아인 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물의 제조방법.
- 제10항에 있어서, 상기 루멘박테리아는 맨하이미아 속 (Mannheimiasp.),액티노바실러스 속 (Actinobacillussp.)및 언에어로바이오스피리륨 (Anaerobiospirillumsp.)으로 구성된 군에서 선택되는 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물의 제조방법.
- 제11항에 있어서, 상기 맨하이미아 속 (Mannheimiasp.)균주는 Mannheimia succiniciproducens PALK (KCTC10973BP)인 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물의 제조방법.
- 제9항에 있어서, 이화산물 저해기작의 약화는 프룩토즈 포스포트랜스퍼라제를 코딩하는 유전자를 결실시켜 수행하는 것을 특징으로 하는 숙숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 변이 미생물의 제조방법.
- 제9항에 있어서, 이화산물 저해기작의 약화는 글리세롤키나제를 코딩하는 유전자를 도입시켜 수행하는 것을 특징으로 하는 숙신산 생산에 수크로오즈와 글리세롤을 동시에 이용가능한 숙신산 생성 변이미생물의 제조방법.
- 제1항 내지 제8항 중 어느 한 항의 변이미생물을 혐기적 조건에서 배양하는 단계 및 상기 배양액으로부터 숙신산을 회수하는 단계를 포함하는 숙신산의 제조방법.
- 제15항에 있어서, 상기 배양은 수크로오스와 글리세롤이 동시에 함유된 배지에서 수행되는 것을 특징으로 하는 숙신산의 제조방법.
- 제15항에 있어서 부산물로서 다른 유기산의 생성량은 숙신산 생성 중량의 1% 이하인 것을 특징으로 하는 방법.
- 다음 단계를 포함하는 숙신산 생성능이 향상된 숙신산의 제조방법:(a) 높은수율을 가지며 부산물 생성이 낮은 숙신산 생산 변이미생물 또는 제1항 내지 제8항 중 어느 한 항의 변이미생물을 혐기적 조건에서 배양하는 단계;(b) 상기 배양액 내의 세포농도를 고농도로 농축시키는 단계;(c) 상기 고농도의 세포를 배양하는 단계; 및(d) 상기 배양액으로부터 숙신산을 회수하는 단계.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2013000662A MY183660A (en) | 2010-08-30 | 2011-08-30 | Novel mutant microorganism producing succinic acid simultaneously using sucrose and glycerol, and method for preparing succinic acid using same |
ES11822105.0T ES2602780T3 (es) | 2010-08-30 | 2011-08-30 | Nuevo microorganismo mutante productor de acido succínico que utiliza sacarosa y glicerol simultáneamente, y método para producir acido succínico utilizando el mismo |
JP2013527009A JP5805768B2 (ja) | 2010-08-30 | 2011-08-30 | スクロースとグリセロールとを同時に利用する新規コハク酸生成変異微生物及びこれを利用したコハク酸製造方法 |
MX2013002394A MX344549B (es) | 2010-08-30 | 2011-08-30 | Nuevo microorganismo mutante productor de acido succinico que utiliza sacarosa y glicerol simultaneamente, y metodo para producir acido succinico utilizando el mismo. |
US13/819,339 US8691516B2 (en) | 2010-08-30 | 2011-08-30 | Mutant microorganism producing succinic acid simultaneously using sucrose and glycerol, and method for preparing succinic acid using same |
AU2011296791A AU2011296791B2 (en) | 2010-08-30 | 2011-08-30 | Novel mutant microorganism producing succinic acid simultaneously using sucrose and glycerol, and method for preparing succinic acid using same |
DK11822105.0T DK2612905T3 (en) | 2010-08-30 | 2011-08-30 | NEW MUTANT MICRO ORGANISM PRODUCING succinic SIMULTANEOUSLY USING SUCROSE AND GLYCEROL, AND METHOD OF PRODUCING succinic USING THIS |
CN201180051937.6A CN103249832B (zh) | 2010-08-30 | 2011-08-30 | 同时利用蔗糖和甘油的新的产琥珀酸突变微生物和利用其生产琥珀酸的方法 |
EP11822105.0A EP2612905B1 (en) | 2010-08-30 | 2011-08-30 | Novel mutant microorganism producing succinic acid simultaneously using sucrose and glycerol, and method for preparing succinic acid using same |
RU2013109055/10A RU2537003C2 (ru) | 2010-08-30 | 2011-08-30 | Мутантный микроорганизм, продуцирующий янтарную кислоту, способ его получения и способ получения янтарной кислоты (варианты). |
NZ607585A NZ607585A (en) | 2010-08-30 | 2011-08-30 | Novel mutant microorganism producing succinic acid simultaneously using sucrose and glycerol, and method for preparing succinic acid using same |
CA2809942A CA2809942C (en) | 2010-08-30 | 2011-08-30 | Novel succinic acid-producing mutant microorganism that utilizes sucrose and glycerol simultaneously and method for producing succinic acid using the same |
BR112013004652-0A BR112013004652B1 (pt) | 2010-08-30 | 2011-08-30 | micro-organismo mutante que utiliza sacarose e glicerol simultaneamente, método para preparação do mesmo e método para produção de ácido succínico utilizando o mesmo |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100084327A KR101221557B1 (ko) | 2010-08-30 | 2010-08-30 | 수크로오즈와 글리세롤을 동시에 이용하는 신규 숙신산 생성 변이 미생물 및 이를 이용한 숙신산 제조방법 |
KR10-2010-0084327 | 2010-08-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012030130A2 true WO2012030130A2 (ko) | 2012-03-08 |
WO2012030130A3 WO2012030130A3 (ko) | 2012-06-28 |
Family
ID=45773370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/006382 WO2012030130A2 (ko) | 2010-08-30 | 2011-08-30 | 수크로오즈와 글리세롤을 동시에 이용하는 신규 숙신산 생성 변이 미생물 및 이를 이용한 숙신산 제조방법 |
Country Status (15)
Country | Link |
---|---|
US (1) | US8691516B2 (ko) |
EP (2) | EP2612905B1 (ko) |
JP (1) | JP5805768B2 (ko) |
KR (1) | KR101221557B1 (ko) |
CN (2) | CN105154381A (ko) |
AU (1) | AU2011296791B2 (ko) |
BR (1) | BR112013004652B1 (ko) |
CA (1) | CA2809942C (ko) |
DK (1) | DK2612905T3 (ko) |
ES (2) | ES2602780T3 (ko) |
MX (1) | MX344549B (ko) |
MY (1) | MY183660A (ko) |
NZ (1) | NZ607585A (ko) |
RU (1) | RU2537003C2 (ko) |
WO (1) | WO2012030130A2 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106164249A (zh) * | 2014-02-07 | 2016-11-23 | 巴斯夫欧洲公司 | 用于基于蔗糖的改善精细化学品产生的修饰微生物 |
WO2020075943A1 (ko) | 2018-10-10 | 2020-04-16 | 한국과학기술원 | 고활성의 말산 탈수소효소가 도입된 숙신산 생성용 변이 미생물 및 이를 이용한 숙신산 제조방법 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100780324B1 (ko) | 2006-07-28 | 2007-11-29 | 한국과학기술원 | 신규 순수 숙신산 생성 변이 미생물 및 이를 이용한 숙신산제조방법 |
US9657316B2 (en) | 2012-08-27 | 2017-05-23 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto |
US11753663B2 (en) | 2012-12-17 | 2023-09-12 | Genomatica, Inc. | Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing adipate, 6-aminocaproate, hexamethylenediamine or caprolactam related thereto |
KR20160134760A (ko) * | 2014-03-19 | 2016-11-23 | 바스프 에스이 | 발효를 위한 탄수화물의 제한적 공급을 사용하는 글리세롤의 용도 |
WO2015169919A1 (en) * | 2014-05-08 | 2015-11-12 | Basf Se | Improved microorganism for succinic acid production |
CN110747147B (zh) * | 2019-11-29 | 2021-05-28 | 江南大学 | 一株衣康酸胁迫抗性提高的大肠杆菌 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009024294A1 (en) | 2007-08-17 | 2009-02-26 | Basf Se | Microbial succinic acid producer mannheimia succini producens ddl |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6159738A (en) | 1998-04-28 | 2000-12-12 | University Of Chicago | Method for construction of bacterial strains with increased succinic acid production |
KR100372218B1 (ko) * | 2000-06-29 | 2003-02-14 | 바이오인포메틱스 주식회사 | 유기산을 생산하는 균주 및 이를 이용한 유기산의 생산방법 |
EP1692271B2 (en) * | 2003-11-27 | 2022-08-03 | Korea Advanced Institute of Science and Technology | Novel rumen bacteria variants and process for preparing succinic acid employing the same |
JPWO2007013695A1 (ja) * | 2005-07-29 | 2009-02-12 | 株式会社日本触媒 | 細菌にグリセリン資化能を付与する方法 |
DE102005047596A1 (de) * | 2005-10-05 | 2007-04-12 | Degussa Ag | Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien |
KR100780324B1 (ko) * | 2006-07-28 | 2007-11-29 | 한국과학기술원 | 신규 순수 숙신산 생성 변이 미생물 및 이를 이용한 숙신산제조방법 |
CN101688176B (zh) * | 2007-04-17 | 2013-11-06 | 味之素株式会社 | 具有羧基的酸性物质的生产方法 |
WO2009048202A1 (en) * | 2007-10-09 | 2009-04-16 | Korea Advanced Institute Of Science And Technology | Method for preparing succinic acid using glycerol as carbon source |
US8691552B2 (en) * | 2008-10-28 | 2014-04-08 | William Marsh Rice University | Microaerobic cultures for converting glycerol to chemicals |
KR101093199B1 (ko) * | 2009-02-12 | 2011-12-12 | 한국과학기술원 | 글리세롤 대사능력 및 숙신산 생산능력이 향상된 재조합 미생물 및 이를 이용한 숙신산의 제조방법 |
MY161185A (en) * | 2009-02-16 | 2017-04-14 | Basf Se | Novel microbial succinic acid producers and purification of succinic acid |
WO2012082720A2 (en) * | 2010-12-13 | 2012-06-21 | Myriant Corporation | Method of producing succinic acid and other chemicals using sucrose-containing feedstock |
CA2841461C (en) * | 2011-07-22 | 2020-05-26 | Myriant Corporation | Fermentation of glycerol to succinic acid by recombinant e. coli |
-
2010
- 2010-08-30 KR KR1020100084327A patent/KR101221557B1/ko active IP Right Grant
-
2011
- 2011-08-30 CN CN201510616196.1A patent/CN105154381A/zh active Pending
- 2011-08-30 ES ES11822105.0T patent/ES2602780T3/es active Active
- 2011-08-30 CN CN201180051937.6A patent/CN103249832B/zh active Active
- 2011-08-30 AU AU2011296791A patent/AU2011296791B2/en active Active
- 2011-08-30 ES ES15188336.0T patent/ES2654512T3/es active Active
- 2011-08-30 MX MX2013002394A patent/MX344549B/es active IP Right Grant
- 2011-08-30 DK DK11822105.0T patent/DK2612905T3/en active
- 2011-08-30 EP EP11822105.0A patent/EP2612905B1/en active Active
- 2011-08-30 JP JP2013527009A patent/JP5805768B2/ja active Active
- 2011-08-30 US US13/819,339 patent/US8691516B2/en active Active
- 2011-08-30 CA CA2809942A patent/CA2809942C/en active Active
- 2011-08-30 MY MYPI2013000662A patent/MY183660A/en unknown
- 2011-08-30 NZ NZ607585A patent/NZ607585A/en unknown
- 2011-08-30 EP EP15188336.0A patent/EP2993225B1/en active Active
- 2011-08-30 RU RU2013109055/10A patent/RU2537003C2/ru active
- 2011-08-30 WO PCT/KR2011/006382 patent/WO2012030130A2/ko active Application Filing
- 2011-08-30 BR BR112013004652-0A patent/BR112013004652B1/pt active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009024294A1 (en) | 2007-08-17 | 2009-02-26 | Basf Se | Microbial succinic acid producer mannheimia succini producens ddl |
Non-Patent Citations (14)
Title |
---|
DEUTSCHER ET AL., MICROBIOL. MOL. BIOL. REV., vol. 70, 2006, pages 939 |
GORKE ET AL., NATURE REVIEWS, vol. 6, 2008, pages 613 |
JANG ET AL., APPL. ENVIRON. MICROBIOL., vol. 73, 2007, pages 5411 |
JANTAMA ET AL., BIOTECHNOL. BIOENG., vol. 99, 2008, pages 1140 |
KUHNERT ET AL., INT. J. SYST. EVOL. MICROBIOL., vol. 60, pages 44 |
LEE ET AL., APPL. ENVIRON. MICROBIOL., vol. 72, 2006, pages 1939 |
MCKINLAY ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 76, 2007, pages 727 |
PETTIGREW ET AL., J. BACTERIOL., vol. 178, 1996, pages 2846 |
ROCHELLE ET AL., FEMS MICROBIOL. LETT., vol. 100, 1992, pages 59 |
See also references of EP2612905A2 |
SONG ET AL., ENZYME MICROBIAL TECHNOL., vol. 39, 2006, pages 352 |
YAZDANI ET AL., CURR. OPIN. BIOTECHNOL., vol. 18, 2007, pages 213 |
ZEIKUS ET AL., APPL. MICROBIOL. BIOTECHNOL., vol. 51, 1999, pages 545 |
ZWAIG ET AL., J. BACTERIOL., vol. 102, 1970, pages 753 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106164249A (zh) * | 2014-02-07 | 2016-11-23 | 巴斯夫欧洲公司 | 用于基于蔗糖的改善精细化学品产生的修饰微生物 |
US9850506B2 (en) | 2014-02-07 | 2017-12-26 | Basf Se | Modified microorganism for improved production of fine chemicals on sucrose |
WO2020075943A1 (ko) | 2018-10-10 | 2020-04-16 | 한국과학기술원 | 고활성의 말산 탈수소효소가 도입된 숙신산 생성용 변이 미생물 및 이를 이용한 숙신산 제조방법 |
US11655462B2 (en) | 2018-10-10 | 2023-05-23 | Korea Advanced Institute Of Science And Technology | Mutant microorganism introduced with highly active malate dehydrogenase for producing succinic acid and method of producing succinic acid using the same |
Also Published As
Publication number | Publication date |
---|---|
MY183660A (en) | 2021-03-05 |
EP2612905A2 (en) | 2013-07-10 |
US20130217087A1 (en) | 2013-08-22 |
NZ607585A (en) | 2014-08-29 |
EP2993225A2 (en) | 2016-03-09 |
ES2654512T3 (es) | 2018-02-14 |
CN103249832B (zh) | 2016-09-21 |
AU2011296791A1 (en) | 2013-04-11 |
BR112013004652B1 (pt) | 2021-05-18 |
RU2537003C2 (ru) | 2014-12-27 |
JP5805768B2 (ja) | 2015-11-10 |
EP2993225A3 (en) | 2016-04-20 |
AU2011296791B2 (en) | 2015-05-21 |
DK2612905T3 (en) | 2016-12-12 |
CA2809942C (en) | 2016-04-12 |
MX344549B (es) | 2016-12-20 |
KR20120020614A (ko) | 2012-03-08 |
WO2012030130A3 (ko) | 2012-06-28 |
EP2612905A4 (en) | 2014-12-17 |
EP2612905B1 (en) | 2016-10-05 |
US8691516B2 (en) | 2014-04-08 |
JP2013539368A (ja) | 2013-10-24 |
CN105154381A (zh) | 2015-12-16 |
RU2013109055A (ru) | 2014-09-10 |
CA2809942A1 (en) | 2012-03-08 |
ES2602780T3 (es) | 2017-02-22 |
CN103249832A (zh) | 2013-08-14 |
EP2993225B1 (en) | 2017-11-29 |
BR112013004652A2 (pt) | 2016-07-05 |
KR101221557B1 (ko) | 2013-01-14 |
MX2013002394A (es) | 2013-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012030130A2 (ko) | 수크로오즈와 글리세롤을 동시에 이용하는 신규 숙신산 생성 변이 미생물 및 이를 이용한 숙신산 제조방법 | |
WO2013105802A2 (ko) | 자일로즈 이용능이 부여된 코리네박테리움 속 미생물 및 이를 이용한 l-라이신의 생산방법 | |
KR100838038B1 (ko) | L-라이신 생산능이 향상된 코리네박테리움 속 미생물 및그를 이용한 l-라이신 생산 방법 | |
WO2010093182A2 (ko) | L-아미노산 생산용 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법 | |
US20130078673A1 (en) | Recombinant microorganism having an ability of using sucrose as a carbon source | |
KR101695605B1 (ko) | 유기산들을 생산하는 대장균의 대사적 진화 | |
WO2012099396A2 (en) | A microorganism having enhanced l-amino acids productivity and process for producing l-amino acids using the same | |
WO2013095071A2 (ko) | L-라이신 생산능을 갖는 미생물을 이용하여 l-라이신을 생산하는 방법 | |
CN105452445B (zh) | 利用用于糖输入的易化扩散生产琥珀酸和其它化学品的方法 | |
WO2013162274A1 (ko) | 신규한 d형 젖산 생산균주 및 그의 용도 | |
WO2014003439A1 (ko) | 에탄올 생산 경로가 봉쇄된 클루이베로마이세스 막시아누스 균주 및 이의 용도 | |
WO2019203436A1 (ko) | 에탄올 생산 경로가 억제된 내산성 효모 및 이를 이용한 젖산의 제조방법 | |
WO2019164346A1 (ko) | L-트립토판을 생산하는 재조합 코리네형 미생물 및 이를 이용한 l-트립토판을 생산하는 방법 | |
WO2021112469A1 (ko) | 신규한 분지쇄 아미노산 아미노트랜스퍼라제 변이체 및 이를 이용한 류신 생산방법 | |
WO2014148754A1 (ko) | 2,3-부탄디올의 생성능이 증강된 재조합 미생물 및 이를 이용한 2,3-부탄디올의 생산 방법 | |
WO2014175663A1 (ko) | L-아르기닌 생산능이 향상된 코리네박테리움속 미생물 및 이를 이용한 l-아르기닌의 생산 방법 | |
WO2015199406A1 (ko) | L-트립토판 생산능을 갖는 에스케리키아속 미생물 및 이를 이용한 l-트립토판의 제조 방법 | |
WO2014126384A1 (ko) | L-쓰레오닌 생산능을 가지는 재조합 에스케리키아 속 미생물 및 이를 이용한 l-쓰레오닌의 생산방법 | |
WO2020067618A1 (ko) | 알파-글루코시다제의 활성이 강화된 l-아미노산을 생산하는 미생물 및 이를 이용한 l-아미노산 생산 방법 | |
KR100630819B1 (ko) | 신규 루멘 박테리아 변이균주 및 이를 이용한 숙신산의제조방법 | |
WO2010093150A2 (ko) | 글리세롤 대사능력 및 숙신산 생산능력이 향상된 재조합 미생물 및 이를 이용한 숙신산의 제조방법 | |
WO2015186958A1 (ko) | O-숙시닐호모세린 또는 숙신산의 생산능을 갖는 미생물 및 이를 이용한 숙신산 또는 o-숙시닐호모세린의 생산 방법 | |
WO2015194900A1 (ko) | 젖산 분해 경로가 봉쇄된 클루이베로마이세스 막시아누스 및 이의 용도 | |
WO2019143089A1 (ko) | 1,3-프로판디올 생성능을 가지는 변이미생물 및 이를 이용한 1,3-pdo의 제조방법 | |
WO2015046978A1 (ko) | 2,3-부탄디올의 생성능이 증강된 재조합 미생물 및 이를 이용한 2,3-부탄디올의 생산 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11822105 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12013500378 Country of ref document: PH |
|
ENP | Entry into the national phase |
Ref document number: 2013527009 Country of ref document: JP Kind code of ref document: A Ref document number: 2809942 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2011822105 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013109055 Country of ref document: RU Ref document number: MX/A/2013/002394 Country of ref document: MX Ref document number: 2011822105 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13819339 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2011296791 Country of ref document: AU Date of ref document: 20110830 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013004652 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013004652 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130227 |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: 112013004652 Country of ref document: BR Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 112013004652 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130227 |